Key facts
- Manuals
- 1
- Categories
- 1
- Languages
- ZH
- Last added
- 2012-01-16
Featured 艾康礼德制药（浙江） manuals
Aikang Lide Pharmaceutical SiLiBa Levodopa Tablets Package Insert
SiLiBa Levodopa Tablets are film‑coated tablets containing the active ingredient levodopa, used to treat refractive amblyopia in children and adolescents. The tablets appear white or off‑white after the coating is removed and are supplied in 0.125 g strength.
The insert details oral dosing regimens for different age groups, lists common adverse reactions such as nausea and orthostatic hypotension, outlines contraindications (e.g., severe cardiovascular disease, glaucoma), and provides precautions, drug‑interaction warnings, and overdose management steps. Storage instructions, packaging details, and regulatory information are also included. This manual is written in Chinese.
Covers: Indications · Dosage and Administration · Contraindications · Adverse Reactions · Precautions · Drug Interactions
Latest 艾康礼德制药（浙江） manuals
Aikang Lide Pharmaceutical SiLiBa Levodopa Tablets Package Insert
Product Leaflet 2 pages · 112 KB · ZHThe package insert for SiLiBa Levodopa Tablets by Aikang Lide Pharmaceutical provides dosage, indications, contraindications, side effects, and storage…
Questions answered in 艾康礼德制药（浙江） manuals
What is the recommended dosage for children aged 5‑6 years?
The recommended dose is 0.125 g (one tablet) taken twice daily, starting with 50 mg (half a tablet) for the first three days.
From: Aikang Lide Pharmaceutical SiLiBa Levodopa Tablets Package Insert
What are the most common adverse reactions?
Common adverse reactions include nausea, vomiting, palpitations, and orthostatic hypotension.
From: Aikang Lide Pharmaceutical SiLiBa Levodopa Tablets Package Insert